The antiserum was produced against synthesized phosphopeptide derived from human NFkappa B p105/p50 around the phosphorylation site of Serine 337.
Our Abpromise guarantee covers the use of ab28849 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/200 - 1/500. Predicted molecular weight: 106 kDa.|
|IHC-P||Use at an assay dependent concentration.|